Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Guyer Insider Profile
4 Followers
David Guyer, EC, Director at IVERIC bio, holds 1.85K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 53.97K shares in IVERIC bio (Ticker: ISEE), holds 0.00 shares in Applied Genetic Technologies (Ticker: AGTC).
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+13.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that David Guyer holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Guyer
David Guyer's Trading History
IVERIC bio
Sep 06, 2016
―
Uninformative Sell
1.27M
$2.16M
EyePoint Pharmaceuticals
Jul 16, 2024
Director
Uninformative Buy
32.65K
$13.13K
Applied Genetic Technologies
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see David Guyer's performance on stock
You May Also Like
David Guyer insider profile FAQ
What is the percentage of profitable transactions made by David Guyer?
The percentage of profitable transactions made by David Guyer is 100%.
What is the average return per transaction made by David Guyer?
The average return per transaction made by David Guyer is 13.60%.
What stocks does David Guyer hold?
David Guyer holds: ISEE, EYPT, AGTC stocks.
What was David Guyer’s latest transaction?
David Guyer latest transaction was an Uninformative Buy of $32.65K.
What was David Guyer's most profitable transaction?
David Guyer’s most profitable transaction was an Informative Sell of EYPT stock on May 16, 2024. The return on the trade was 30.40%.
What is David Guyer's role in IVERIC bio?
David Guyer's role in IVERIC bio is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.